Eptifibatide

FDA Approved: * June 5, 2015
Pharm Company: * TEVA PHARMS USA
Category: Intravenous (IV) Therapy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eptifibatide Overview

Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inh...

Read more Eptifibatide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eptifibatide

Recent Eptifibatide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Eptifibatide: (21 results)

Showing the first 20, Sorted by National Drug Code

• 0338-9558 Eptifibatide 75 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
• 0338-9559 Eptifibatide 200 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
• 0703-1165 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
• 0703-1179 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
• 16729-259 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
• 16729-260 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
• 17478-902 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Akorn, Inc.
• 17478-903 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Akorn, Inc.
• 25021-408 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
• 25021-409 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
• 55150-218 Eptifibatide 75 mg/100ml Intravenous Injection by Auromedics Pharma LLC
• 55150-219 Eptifibatide 20 mg/10ml Intravenous Injection by Auromedics Pharma LLC
• 55150-220 Eptifibatide 200 mg/100ml Intravenous Injection by Auromedics Pharma LLC
• 59651-012 Eptifibatide 75 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
• 59651-013 Eptifibatide 20 mg/10ml Intravenous Injection by Aurobindo Pharma Limited
• 59651-014 Eptifibatide 200 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
• 67457-629 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
• 67457-630 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
• 67457-631 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
• 70121-1002 Eptifibatide 2 mg/ml Intravenous Injection by Amneal Biosciences
• 1 more results ...

Other drugs which contain Eptifibatide or a similar ingredient: (1 result)

• INTEGRILIN Eptifibatide1 discussion